USBCTechnology · Scientific & Technical InstrumentsUSBC Stock Forecast: USBC, Inc. Price Predictions for 2026-2027
Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 6 of 100 as at 22 Aug 2026 — in the weakest quartile.
USBC stock analysis: one number for the whole business
Consensus tells you what everyone already believes. The model scores USBC, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (71): Smaller than most of the companies we track.
Issuance (3): The company has been issuing shares or taking on financing, diluting existing holders.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
USBC stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on USBC, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
This page is one stock. Monday covers all of them.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. USBC appears on the weeks it earns a place.
USBC analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
USBC, Inc. (USBC) financial data
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- −1.1×
- Price / sales
- —
- Price / book
- 2.7×
- EV / EBITDA
- −1.8×
Cheaper than 83% of US stocks
Cheaper than 38% of US stocks
Cheaper than 70% of US stocks
- Revenue growth (YoY)
- —
- Earnings growth (YoY)
- —
- Gross margin
- —
- Operating margin
- 0.0%
- Net margin
- 0.0%
Higher than 32% of US stocks
Higher than 30% of US stocks
- Return on equity
- −25.1%
- Return on assets
- −19.5%
- Dividend yield
- 296.7%
Higher than 29% of US stocks
Higher than 20% of US stocks
Higher than 99% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
USBC vs competitors
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own USBC, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Frequently asked questions about USBC stock
How does Ticker Nerd's model rank USBC?
As at 22 Aug 2026, USBC, Inc. ranks 6 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (71 of 100).
What is the USBC stock forecast for 2030?
No analyst covering USBC, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for USBC are extrapolating price history, which says nothing about the business.
How has USBC stock performed over the past year?
USBC, Inc. returned -62.1% over the 12 months to 24 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
What does USBC, Inc. do?
US BioTec, Inc. is a biotechnology company that develops, manufactures, and distributes biodegradable, nontoxic, and noncarcinogenic products designed to support soil health and plant growth.
About USBC, Inc.
US BioTec, Inc. is a biotechnology company that develops, manufactures, and distributes biodegradable, nontoxic, and noncarcinogenic products designed to support soil health and plant growth. The company's portfolio includes approximately 30 products that stimulate crop production, address microbial and mineral deficiencies in soils, and help rehabilitate soil ecosystems by breaking down residual toxic buildup from insecticides, herbicides, fungicides, and synthetic fertilizers. US BioTec serves diverse markets including agriculture, commercial turf management, forestry, golf courses, professional landscaping, nurseries, and mass market retail lawn and garden sectors. Based in Gleason, Tennessee, and founded in 1998, the company provides environmentally sustainable solutions for agricultural and horticultural applications, helping clients restore soil quality and improve crop yields through specialized biological products.
CEO Mr. Robert Gregory Kidd · 16 employees · United States · https://investors.usbc.xyz